Purchase Order HHSN268201500035A

The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson and Company (BD Biosciences) for an LSRFortessa multi-year maintenance agreement with a ceiling value of $283,987.80, awarded November 17, 2014, with ultimate completion November 20, 2019. Place of performance is Bethesda, Maryland. The order is firm fixed price with no set-aside. This is a maintenance agreement supporting flow cytometry instrumentation at a federal research facility, typical of BD...

The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson And Company (BD Biosciences division) for $29,376.00 on February 10, 2015, with an ultimate completion date of March 14, 2016. The order covers a FACSARIA II special order system maintenance agreement, priced on a firm fixed price basis with no set-aside. Work is performed at Bethesda, Maryland. This is a commercial item procurement for flow cytometry system maintenance, consistent with BD Biosciences'...

<p>The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson And Company (BD Biosciences division) on November 21, 2019, for $36,770.65 with a firm fixed price for BD LSRFORTESSA maintenance services, with ultimate completion on September 30, 2020. Work is performed at Bethesda, Maryland. No set-aside applies.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson And Company (BD Biosciences division) on January 25, 2016, for $88,004.44 to provide maintenance service on LSRFORTESSA equipment with an ultimate completion date of January 31, 2017. Performance occurs in San Jose, California. The order is firm fixed price with no set-aside.</p>

The National Heart Lung and Blood Institute issued a delivery order to Becton, Dickinson And Company (BD Biosciences division) on October 19, 2012, with a ceiling value of $32,485.20 for service and maintenance of a four-laser flow cytometry instrument (model Fortessa, serial H79900001) located in Bethesda, Maryland. The order ran from December 1, 2012 through November 30, 2013 under firm fixed price terms. Work was performed at the National Heart Lung and Blood Institute facility in Bethesda,...

<p>The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson and Company (BD Biosciences) on January 13, 2019, for BD Fortessa flow cytometer maintenance services with a ceiling value of $37,409.40 and an ultimate completion date of January 12, 2020. Work is performed in Bethesda, Maryland. The contract carries firm fixed-price terms and no small business set-aside.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson And Company (BD Biosciences division) for $38,127.60 on August 30, 2019, for BD Biosciences FACSAria maintenance agreement services, with ultimate completion on August 29, 2020. Place of performance is Bethesda, Maryland. The order is firm fixed price with no small business set-aside.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson and Company (BD Biosciences) for a maintenance agreement valued at $32,562.00, with an award date of February 28, 2019 and completion date of March 14, 2020. Place of performance is San Jose, California. The order is priced on a firm fixed price basis with no small business set-aside.</p>

<p>The National Heart Lung and Blood Institute issued a delivery order to Becton, Dickinson And Company (BD Biosciences division) on November 20, 2015, with a ceiling value of $11,756.40 for renewal of a maintenance agreement for a flow cytometer machine.</p> <p>Place of performance is Bethesda, Maryland. The order is firm fixed price with an ultimate completion date of November 14, 2016. No set-aside was used.</p>

Becton, Dickinson and Company (BD) was awarded a firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health's National Heart, Lung and Blood Institute to provide maintenance services for a BD Biosciences Fortessa flow cytometer. The potential value of this contract is $147,863.40. No set-aside designation was used for this award. Performance will occur in Bethesda, Maryland and continue through January 31, 2025. This award is associated with the...